With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been peer-reviewed. Females in the study were twice as likely to lose hair as males.

Novo Nordisk NVO and Jazz Pharmaceuticals JAZZ reported their first-quarter results. AstraZeneca’s AZN late-stage asthma ...

Medically reviewed by Femi Aremu, PharmD Ozempic and Wegovy are both glucagon-like peptide-1 (GLP-1) receptor agonists and contain the active ingredient semaglutide. They share many similarities, and ...

The Trump administration could try to steer every Medicare recipient into private coverage via the Medicare Advantage program. Congress is geared for an explosive public fight over catastrophic ...

If a person’s Medicare plan requires prior authorization, their doctor will typically take responsibility for submitting the request. A person may need to complete certain forms beforehand.

In a press release, the Danish drugmaker said that from July 1, CVS Caremark, the largest pharmacy benefit manager in the U.S., has agreed to make Wegovy ... $517.4M in the prior year quarter.

Eli Lilly has reported $12.73bn in Q1 2025 revenue, a 45% increase from the prior year ... will make its weight loss drug Wegovy (semaglutide) the preferred glucagon-like receptor 1 agonist ...

In a major clinical trial, the weight loss drug Wegovy has been able to treat a serious form of liver disease in the majority of patients, according to the findings published in the New England ...

The weight loss drug Wegovy treated a serious form of liver disease in about two ... compared with 34.3% of people who got a placebo. Prior to starting the trial, the participants also had ...